InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

August 24, 2026 — Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct the preclinical validation needed to determine the program’s next development steps. VXA-222 uses an “AND-gate” approach designed to recognize two tumor-associated antigens simultaneously before delivering its therapeutic payload.


NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports First-Half 2026 Results, Advances Expanded U.S. Clinical Manufacturing Program

August 24, 2026 — Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), reported first-half 2026 revenue of $949,000, up from $773,000 in the prior-year period, while committed customer orders reached approximately $3. 1 million as of Aug.


InvestorNewsBreaks – Market Street Capital Inc. Helps Founders Navigate Expanding Private Credit Landscape

August 21, 2026 — Market Street Capital was featured in a recent article that discusses how the expanding private credit sector is giving middle-market founders more options when evaluating debt and equity financing. The article explores the long-term implications of each approach, noting that debt can preserve ownership and provide cost-efficient capital for established businesses with predictable cash flows, while equity can offer greater flexibility for transformational initiatives but comes with ownership dilution and potential changes in governance.


MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Clinical Development Path for Next-Gen Cancer Therapy

August 21, 2026 — VERAXA Biotech (NASDAQ: VRXA) recently received favorable Scientific Advice from Germany’s Paul-Ehrlich-Institute (“PEI”) regarding the development strategy for its lead BiTAC-TCE cancer therapy, providing regulatory guidance on the program’s biological rationale, pharmacokinetics and planned non-clinical safety studies ahead of potential clinical trials. The company views the feedback as an early regulatory validation that could reduce development uncertainty and clarify the path toward the clinic.


Wrap Technologies Inc. (NASDAQ: WRAP) Builds Connected Public Safety Strategy as WrapShield(TM) Targets Broader Markets

August 21, 2026 — WRAP is using newly raised $12 million in growth capital to support planned business expansion and accelerate development of its WrapShield(TM) platform. The company is connecting technologies spanning detection, response, training and evidence management as it expands beyond traditional law enforcement into enterprise, federal, defense and international markets.


Researchers Test Simple Fix That Saves Time Spent in ERs

August 21, 2026 — A new study has confirmed that a simple fix in the way patients are treated in emergency rooms (ERs) can speed up care and reduce the amount of time patients wait before being attended to. The fix involves treating selected patients while they are seated instead of waiting for an ER bed to become available so they can be attended to.


China Leads in Renewable Energy Waste as Grids Struggle to Cope

August 21, 2026 — China is highlighting a growing problem in the global transition to renewable energy: electricity grids are struggling to absorb rapidly expanding supplies of renewable power. The projects being undertaken by companies like MAX Power Mining Corp.


Sales of Used Electric Vehicles Continue Surging, Data Shows

August 21, 2026 — Sales of used electric vehicles (EVs) continued to rise in July, showing that demand for affordable electric cars remains strong even as the wider new-EV market faces serious challenges. The question now becomes: How can EV makers like Lucid Motors (NASDAQ: LCID) bridge the gap between robust used… Read More>> About BillionDollarClub BillionDollarClub (“BDC”) is a specialized communications platform with a focus on the biggest and brightest companies covered by IBN.


What the World Could Learn from China’s EV Dominance

August 21, 2026 — The world’s policymakers and automakers have real lessons to draw from how China built its electric vehicle industry, and the useful ones have little to do with copying an all-powerful state. Start with technological range: China backed multiple pathways simultaneously, battery-electric, hybrid, fuel-cell, and alternative fuels, rather than committing early to one winner.